Jeffrey S. Price
Directeur Général chez Octamer, Inc.
Postes actifs de Jeffrey S. Price
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Octamer, Inc.
 Octamer, Inc. Pharmaceuticals: MajorHealth Technology Octamer, Inc. develops pharmaceutical products for acquired immunodeficiency syndrome virus and cancer cells. The company was founded on June 13, 1990 and is headquartered in Walnut Creek, CA. | Directeur/Membre du Conseil | - | - |
| Directeur Général | - | - | |
| Directeur Financier/CFO | - | - | |
Planet Biotechnology, Inc.
 Planet Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Planet Biotechnology, Inc. identifies and develops promising antibodies and receptor-antibody fusion molecules for the treatment and prevention of infectious diseases including emerging diseases and bio-threat agents. The company was is headquartered in Hayward, CA. | Président | 01/01/1998 | - |
Historique de carrière de Jeffrey S. Price
Anciens postes connus de Jeffrey S. Price
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Cetus Corp. | Directeur Technique/Scientifique/R&D | - | - |
PanGenetics BV
 PanGenetics BV Miscellaneous Commercial ServicesCommercial Services PanGenetics BV researches and develops antibody-based therapeutic products. It specializes in taking antibodies at the late research stage through to clinical proof of concept. The firm’s advanced programs are PG102, a CD40 antagonist, and PG110, an anti-Nerve Growth Factor antibody for use in chronic pain. The company was founded by Mark de Boer and James W. Larrick in 1995 and is headquartered in Utrecht, the Netherlands. | Directeur/Membre du Conseil | - | - |
Statistiques
Internationale
| Etats-Unis | 4 |
| Pays-Bas | 2 |
Opérationnelle
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| Director of Finance/CFO | 1 |
Sectorielle
| Health Technology | 4 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 4 |
|---|---|
PanGenetics BV
PanGenetics BV Miscellaneous Commercial ServicesCommercial Services PanGenetics BV researches and develops antibody-based therapeutic products. It specializes in taking antibodies at the late research stage through to clinical proof of concept. The firm’s advanced programs are PG102, a CD40 antagonist, and PG110, an anti-Nerve Growth Factor antibody for use in chronic pain. The company was founded by Mark de Boer and James W. Larrick in 1995 and is headquartered in Utrecht, the Netherlands. | Commercial Services |
Octamer, Inc.
Octamer, Inc. Pharmaceuticals: MajorHealth Technology Octamer, Inc. develops pharmaceutical products for acquired immunodeficiency syndrome virus and cancer cells. The company was founded on June 13, 1990 and is headquartered in Walnut Creek, CA. | Health Technology |
| Cetus Corp. | Health Technology |
Planet Biotechnology, Inc.
Planet Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Planet Biotechnology, Inc. identifies and develops promising antibodies and receptor-antibody fusion molecules for the treatment and prevention of infectious diseases including emerging diseases and bio-threat agents. The company was is headquartered in Hayward, CA. | Health Technology |
- Bourse
- Insiders
- Jeffrey S. Price
- Expérience
